If you are using inhalers by GlaxoSmithKline, you have probably heard the news. The ones that are not familiar with it, need to understand that these inhalers come with a defect.
The FDA issued a statement in which they stated that GSK recalled a large amount of their inhalers. We’re talking about roughly 600,000 asthma inhalers. The inhalers were withdrawn due to the fact that they had a defective delivery system. The company recalled their product voluntarily.
This problem is not unsafe for the customers, however they can return it anyway. GSK stated that they do not expect this issue to have an effect on the supply of Ventolin HFA 200D inhaler. The defective design is Ventolin HFA inhaler.
The company and their statement
The company states that their products are always safe and of the highest quality, which their priority is the satisfaction of their customers.
You can enjoy the video listed below, to find out more: